BMS and AstraZeneca terminate Phase III ACS trial due to likely failure
Analysts believe the ACS failure may suggest failure in the Phase III stroke trial.
17 November 2025
17 November 2025
Analysts believe the ACS failure may suggest failure in the Phase III stroke trial.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.